Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

21.75
Delayed Data
As of Aug 16
 +0.04 / +0.18%
Today’s Change
13.01
Today|||52-Week Range
22.17
+15.94%
Year-to-Date

Today’s Trading

Previous close21.71
Today’s open21.70
Day’s range21.70 - 21.76
Volume226,765
Average volume (3 months)1,220,719
Market cap$936.1M
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+18.60%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.36%
P/E ratioNM
Price/Sales1.26
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...-0.09-2.88%
RGNXRegenxbio Inc+0.75+3.50%
MEDPMedpace Holdings Inc-0.16-0.51%
CLXTCalyxt Inc-0.43-3.44%
Data as of 08/16/2017

Financials

Last reporting dateAugust 17, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$568.8M
Annual profit (last year)-$70.2M
Net profit margin-12.34%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts